Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. [PDF]
Espinola N +7 more
europepmc +1 more source
[SARS-CoV-2 antibodies after booster vaccination. Identification of subgroups with poor response]. [PDF]
Ayuso García B +6 more
europepmc +1 more source
[Autoimmunity and Freiburg classification in common variable immunodeficiency]. [PDF]
Herrera-Sánchez DA +5 more
europepmc +1 more source
Recurrent Pericarditis After Covid-19. [PDF]
Rodrigo Domínguez D +5 more
europepmc +1 more source
[Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)]. [PDF]
Caso-González A +5 more
europepmc +1 more source
Nanopartículas para la artritis reumatoide
La artritis reumatoide (AR) es una enfermedad inflamatoria autoinmune asociada a la inflamación crónica de la membrana sinovial, lo que causa la destrucción del cartílago y el hueso circundante provocando dolor, rigidez, hinchazón e incluso la pérdida de la función articular, cuya etiopatogenia aún se desconoce, y es causante de discapacidad.
openaire +1 more source
What We Know to Date About Early Treatment With Biologics in Severe Asthma: A Scoping Review About the Use of Biologics in Severe Asthma and Possible Parallels With Early Rheumatoid Arthritis. [PDF]
Pérez-de Llano L +4 more
europepmc +1 more source
Factores medioambientales y artritis reumatoide
openaire +3 more sources

